N atural killer T cells are CD1d-restricted, lipid Ag-reactive, ab T cells that are present in mice and humans. There are two broad classes of NKT cells: the most extensively studied are those classified as type I NKT cells, which mostly express an invariant TCR a-chain paired with a limited, but not invariant, array of TCR b-chains. In contrast, type II NKT cells, although also CD1d-restricted and lipid Ag reactive, express more diverse TCR a-and b-chains and appear to recognize different lipid Ags from those detected by type I NKT cells. This study is focused on type I NKT cells, which we simply refer to as NKT cells. In mice, NKT cells typically express an invariant Va14-Ja18 TCR a-chain paired with either Vb8, Vb7, or Vb2, whereas in humans, most of these cells use the orthologous Va24-Ja18 TCR a-chain paired with Vb11 (1). However, in both mice and humans, TCR b-chain diversity is generated through the use of variable TCR Db and Jb genes and non-germline-encoded nucleotide additions during TCR b-chain gene rearrangement, thus resulting in a high level of CDR3b loop diversity and a polyclonal repertoire in both species (2) (3) (4) (5) . Furthermore, despite their limited TCR diversity, NKT cells recognize a diverse array of exogenous and endogenous CD1d-restricted ligands, which coincides with the participation of these cells in a range of different diseases (6, 7) .
Whether the TCR b-chain can influence lipid Ag specificity of NKT cells has been a controversial and long-standing question. Earlier studies provided evidence that in mice, Vb7 + NKT cells were selectively expanded or selected in response to self-lipid Ags, such as isoglobotrihexosylceramide (iGb3) and a-glucosylceramide (a-GlcCer) presented by CD1d (8) (9) (10) (11) , whereas others had suggested that the TCR b-chain primarily modulated the affinity of TCR binding to CD1d, independently of the lipid Ag that was presented by CD1d (12) (13) (14) . Florence et al. (15) reported that different CDR3b loops modified through alanine substitution at different residues in the context of a Vb8 + NKT TCR differentially influenced glycolipid Ag recognition in the context of CD1d. Structural studies examining NKT TCR interactions have indicated that the TCR b-chain binds to CD1d but does not come into direct contact with the Ag (6, 7) . However, the TCR b-chain can indirectly impact on the binding affinity through differential interactions with CD1d (16, 17) and, furthermore, via modulating the TCR a-chainAg interactions (18) . This raises the possibility that the NKT cell TCR b-chain can contribute to Ag specificity of these cells.
In this study, data are provided that support an important role for the TCR b-chain involving both germline-encoded (Vb and Jb) and non-germline-encoded residues working in a complementary manner in determining lipid Ag specificity of NKT cells. This suggests that the TCR b-chain can influence the recognition of particular glycolipid Ags presented by CD1d.
Materials and Methods

Glycolipids
The glycolipid Ags used in this study were either commercially purchased [a-galactosylceramide (a-GalCer; C26) (19) , OCH (20) , and iGb3 and Gb3 (21) from Enzo Life Sciences; b-GalCer (C12) (22) from Avanti Polar Lipids] or synthesized as previously described [a-GalCer (C20:2) (23), a-GlcCer (C20:2) (24), a-GlcCer (C26) (19) (26) , a-GalCer (C24:1)/PBS-44 (27) , a-glucuronosylceramide (GSL-1) and a-galacturonosylceramide (GSL-19) (28), and a-glucuronosyl diacylglycerol (a-GlcA-DAG) (29) 
CD1d tetramers
Mouse and human CD1d tetramers were produced using a baculovirus expression system, similar to that previously described (30) . Glycolipids were incubated with purified CD1d-biotin at 6:1 or 30:1 (lipid/protein) molar ratios at 37˚C overnight. When required, CD1d-biotin stock was diluted with 10 mM Tris (pH 8.0) prior to the addition of glycolipid to ensure the concentration of vehicle reagent did not exceed 33% (v/v). Streptavidin-PE (BD Biosciences), streptavidin-allophycocyanin (BD Biosciences), or streptavidin-Brilliant Violet 421 (BioLegend) was used to generate tetramers. iGb3-loaded CD1d tetramer staining required iGb3 stock to be prepared in tyloxapol-based vehicle reagent.
Single-cell TCR sequencing
RNA was extracted from sort-purified mouse and human NKT cells, and cDNA was synthesized using a Sensiscript reverse transcription kit (Qiagen) (31) or SuperScript VILO cDNA synthesis kit (Invitrogen), respectively. Transcribed cDNA was amplified by two rounds of nested PCR amplification, as previously described (31, 32) . PCR product was purified using a QIAquick PCR purification kit (Qiagen). Dye terminator sequencing reaction was performed using BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems) prior to sequencing electrophoresis (Molecular Diagnostics).
Generation of TCR-transduced NKT cell lines
Individual NKT cell TCR constructs containing TCRa and TCRb genes separated by a 2A linker were synthesized (GenScript) and inserted into pMIG2 vectors essentially as previously described (33) . Human embryonic kidney (293T) cells were transfected with 4 mg TCR expression vector, 2 mg pMIG expression vector containing CD3 sequence (a gift from S. Turner, University of Melbourne), 4 mg packaging vector pEQ-Pam3(-E), and 2 mg packaging vector pVSV-G using FuGENE 6 transfection reagent (Promega). Retrovirus containing supernatant was collected twice daily and used to transduce a TCR-deficient mouse thymoma cell line (BW58) in the presence of Polybrene (Sigma-Aldrich) for a total of 4 d.
In vitro proliferation assay
Splenocytes from Ja18 2/2 mice were pulsed overnight with iGb3 or a-GalCer in 48-well flat-bottom plates (3 3 10 6 cells/well), harvested, and washed with fresh media to remove excess glycolipid. Wild-type thymocytes were enriched for NKT cells by complement depletion of anti-CD24-and anti-CD8-labeled cells. Dead cells were removed via Histopaque-1083 (Sigma-Aldrich) density gradient centrifugation. Thymocytes were then labeled with either 2 mM CFSE (Molecular Probes) or 1 mM CellTrace Violet (Invitrogen) and incubated for 10-15 min at 37˚C. Splenocytes (3 3 10 5 /well) and thymocytes (5 3 10 4 /well) were cocultured for 72 h in 96-well round-bottom plates.
Cell surface staining
In vitro-stimulated cells were stained with 7-aminoactinomycin D (SigmaAldrich) for exclusion of nonviable cells, anti-CD45R/B220-allophycocyaninCy7 (BD Biosciences, RA3-6B2), a-GalCer (PBS-44)-loaded CD1d tetramer (PE), and anti-TCRb-allophycocyanin (BD Biosciences, H57-597). For Vb analysis, anti-TCRb was excluded from the Ab mixture and replaced with anti-CD3 (145-2C11). Subsequently, cells were stained using a panel of anti-Vb-FITC (BD Biosciences). Proliferative responses were assessed using a BD LSR II, LSRFortessa, or BD FACSCanto II flow cytometer and FlowJo (Tree Star) software. TCR-transduced NKT cell lines were stained with anti-CD3-Pacific Blue (eBioscience, 17A2) or anti-CD3-Brilliant Violet 421 (BioLegend, 17A2) and anti-TCRb-allophycocyanin (BD Biosciences, H57-597) at 4˚C for 30 min, followed by glycolipid-loaded CD1d tetramer (PE) at room temperature for 30 min. CD1d tetramer staining experiments of retrovirally transduced BW58 cell lines were performed using a BD LSRFortessa. Mouse CD1d tetramer costaining experiments were performed on NKT cell-enriched thymocytes simultaneously incubated with saturating concentrations of a-GalCer (analogs)-loaded CD1d tetramer (allophycocyanin or Brilliant Violet 421) and a-GlcCer (analogs)-loaded CD1d tetramer (PE) at 37˚C for 30 min. For Vb analysis, cells were then chilled on ice for 5 min and stained with antiVb-FITC at 4˚C for 30 min. Human CD1d tetramer costaining experiments were performed on in vitro-expanded NKT cells simultaneously incubated with saturating concentrations of a-GalCer (analogs)-loaded CD1d tetramer (Brilliant Violet 421) and a-GlcCer (analogs)-loaded CD1d tetramer (PE) at 37˚C for 30 min. CD1d tetramer costaining experiments were performed using a BD LSRFortessa.
Human NKT cell enrichment and expansion
Blood samples from healthy volunteers were obtained from the Australian Red Cross Blood Service, with ethics approval from both Red Cross (approval no. 11-05VIC-12) and University of Melbourne Human Research and Ethics Committee (approval no. 1035100). PBMCs were isolated and NKT enriched/expanded as previously described (34) . Briefly, CD1d-aGalCer tetramer + NKT cells were enriched using anti-PE magnetic beads (Miltenyi Biotec) and cell sorting, followed by stimulation in vitro with anti-CD3/anti-CD28/PHA/IL-2/IL-7 for 48 h, followed by maintenance with IL-2 and IL-7 for 14-21 d.
Results
iGb3 recognition is restricted to a subset of NKT cells iGb3 is a mammalian glycolipid and when presented by CD1d acts as a weak agonist for NKT cells in mice (9, 21) . Some studies have suggested that Vb7 + NKT cells are more responsive to iGb3 than are Vb7 2 NKT cells (8, 9) , although this is not always observed (12) . We investigated this further by labeling mouse NKT cellenriched thymocytes with a fluorescent dye (CellTrace Violet) to track cell division, stimulating these cells in vitro in the presence of spleen cells from NKT cell-deficient Ja18 2/2 mice with either iGb3 (10 mg/ml) or a-GalCer (100 ng/ml) (Fig. 1A) , and comparing the proportions of Vb2, Vb7, Vb8.1/8.2, and Vb8.3 + NKT cells among the proliferating fractions with those from unstimulated (preculture, day 0) NKT cells (Fig. 1B, 1C ). Most notably, the percentage of Vb7 + NKT cells was consistently increased in the iGb3-responsive fraction and decreased in the a-GalCer-responsive fraction, compared with preculture NKT cells (Fig. 1B, 1C ). Corresponding to the increase in Vb7 + NKT cells in the iGb3-responsive fraction, there was also a significant reduction in Vb2 + cells. Most NKT cells in the cultures were proliferating following 3 d in vitro culture with either a-GalCer or iGb3 Ags; however, a larger portion of the population remained undivided, even when exposed to a 100-fold higher concentration of iGb3 (Fig. 1A) . Proliferation analysis software, which accounts for the exponential expansion of dividing cells, suggested that only a minor subset of the starting population of NKT cells was responding to iGb3 in (Fig. 1D, 1E ). This is consistent with the relative expansion of Vb7 + NKT cells when cultured with iGb3 in the present study and in other studies (8, 9) . Collectively, these data suggest that iGb3 is capable of activating a subset of NKT cells and that a higher proportion of Vb7 + NKT cells are iGb3-responsive compared with NKT cells expressing other Vb-chains.
To directly test whether some NKT cells are simply unable to respond to iGb3, CFSE-labeled thymocytes enriched for NKT cells were stimulated in vitro for 3 d with 10 mg/ml iGb3 ( Fig. 2A) , and undivided thymocytes (including iGb3-unresponsive NKT cells) were purified by flow cytometry, based on a lack of CFSE dilution to exclude divided cells, as well as the exclusion of large cells to remove potentially activated cells that were yet to proliferate (Fig. 2B ). CD1d tetramer was not used to purify NKT cells in this experiment, as this may have activated the cells. The FACS-sorted undivided cells were then restimulated with iGb3 (10 mg/ml), a-GalCer (100 ng/ml), or no glycolipid. After 2-3 more days, the vast majority of NKT cells in these cultures had divided following exposure to a-GalCer, indicating that iGb3-unresponsive cells from the initial culture were competent to proliferate to an appropriate antigenic stimulus (Fig. 2C) ; however, following reculture with iGb3, very little Ag-induced NKT cell proliferation was evident (Fig. 2C) . These data suggest that the recognition of the mammalian Ag iGb3 is restricted to a subset of the NKT cell population, whereas iGb3-unresponsive cells are still capable of responding to more broadly activating Ags such as a-GalCer.
TCR Jb usage influences Ag recognition
Despite the evidence that only a subset of NKT cells appeared to respond to iGb3, TCR Vb usage alone was unlikely to account for the restricted recognition because NKT cells from each of the major Vb subsets showed differential responses to iGb3 (Vb7 . Vb8 . Vb2) (Fig. 1D) . Another possibility was that iGb3 responsiveness was partly mediated by the hypervariable CDR3b loop. To examine this, CFSE-labeled thymocytes enriched for NKT cells were stimulated for 3 d with 100 ng/ml iGb3, which is typically a suboptimal dose (Supplemental Fig. 1 ), or the maximum dose of 10 mg/ml. NKT cells were then single cell sorted based on CFSE staining intensity to separate divided and nondivided cells and the expression of either Vb7 or Vb8.1/8.2. Isolated cells were then examined using PCR amplification with nested primers specific for either Vb7 or Vb8.1/8.2 and the TCRb C region (31, 32, 35) . Using this approach, .650 single NKT cell TCR b-chains were examined. The iGb3-responsive NKT cells were predominantly polyclonal, with 247 of the 336 TCR b-chain sequences being unique at the nucleotide level. In the nondivided fraction, 312 of the 338 sequences were unique, highlighting the diversity of the NKT cell TCRb repertoire (3) . Although analysis of CDR3b sequences failed to reveal any obvious trends that could explain the differential reactivity to iGb3 (Supplemental Fig. 2 ), the distribution of Jb sequence usage was heavily biased between divided and nondivided fractions (Fig. 3) . Furthermore, trends in Jb distribution were distinct between Vb7-and Vb8. 1 
NKT cell TCR b-chain composition confers differential Ag recognition
To establish whether NKT TCR b-chain composition is directly responsible for iGb3 recognition, a selection of TCRs derived from NKT cells that were either responsive of nonresponsive to iGb3 were used to generate a panel of TCR-transduced cell lines.
To examine the role of divergent CDR3b sequence usage in the context of the same Vb-Jb paring, two Vb8.2-Jb2.7-responsive (Vb8.2-Jb2.7r1 and Vb8.2-Jb2.7r2) and two Vb8.2-Jb2.7-nonresponsive sequences (Vb8.2-Jb2.7n1 and Vb8.2-Jb2.7n2) were selected, alongside one responsive Vb7-Jb1.2 (Vb7-Jb1.2r) and one nonresponsive Vb7-Jb1.2 sequence (Vb7-Jb1.2n) (Fig. 4A) .
Given that Vb8 + cells that expressed Jb2.4 were unable to respond to iGb3 (Fig. 3) , two of these sequences were also selected from the iGb3 nonresponsive cells (Vb8.2-Jb2.4n1 and Vb8.2-Jb2.4n2). Each of these TCR b-chains was coupled with the invariant Va14-Ja18 TCR a-chain prior to retroviral transduction. With the intention of isolating TCR sequences with highest responsiveness to iGb3, all responsive sequences were selected from as gauged by CellTrace Violet or CFSE dilution. Data are pooled from seven independent experiments. Statistical significance was assessed by a Friedman test followed by a Dunn posttest comparison. *p , 0.05, ***p , 0.0005. NKT cells that proliferated to the lower dose of iGb3 (100 ng/ml) with the exception of one iGb3-responsive clone that used a Vb8.2-Jb2.5 pairing (Vb8.2-Jb2.5r), chosen from a 10 mg/ml iGb3-stimulated culture because this was the largest clonal population identified among iGb3-responsive cells (data not shown). Conversely, to investigate TCRs that were nonresponsive to iGb3, sequences were taken from NKT cells that failed to proliferate following high-dose iGb3 exposure (10 mg/ml) (Fig. 4A) . Cell lines were subsequently tested with CD1d tetramers loaded with either iGb3, Gb3, a-GalCer, or vehicle alone. CD1d tetramer staining intensity was measured on cells gated for a comparable level of TCR expression by each cell line. As predicted, iGb3-responsive TCRs (Vb7-Jb1.2r, Vb8.2-Jb2.5r, Vb8.2-Jb2.7r1, and Vb8.2-Jb2.7r2) conferred superior binding of iGb3-loaded CD1d tetramer (Fig. 4B) . Interestingly no such pattern was observed when these cell lines were stained with a-GalCer-loaded CD1d tetramer, and Gb3-loaded tetramer failed to stain any of these cell lines. These data confirmed that both Vb-Jb pairing and non-germlineencoded variation within the CDR3b region can facilitate iGb3 recognition by NKT cells, demonstrating a context-dependent role for the hypervariable CDR3b region. Interestingly, some cell lines expressing TCRs from nonresponsive NKT cell clones, including Vb8.2-Jb2.7n2 and Vb7-Jb1.2n, exhibited weak reactivity to iGb3-loaded CD1d tetramer compared with the control Gb3-loaded tetramer, but this required a higher level of TCR expression relative to iGb3-responsive cell lines. This is demonstrated in Fig. 4C comparing Vb8.2-Jb2.7r2 staining with iGb3-loaded or Gb3-loaded CD1d tetramer versus TCRb (without the narrow TCRb gate that was used in Fig. 4B ), relative to the nonresponsive cell lines Vb8.2-Jb2.7n2, Vb7-Jb1.2n, and Vb8.2-Jb2.4n1. These data suggested that, in some instances, reactivity to CD1d-iGb3 by NKT TCRs could be influenced by both TCR b-chain composition and affinity, as well as the level of TCR expression, and thus avidity.
Given that these NKT cell lines displayed differential recognition of iGb3 and a-GalCer, the reactivity of other CD1d-restricted glycolipid Ags was also investigated. These included mammalian b-GalCer analog C12 [b-GalCer (C12)] (22, 36), tumor-associated Ag a-L-FucCer (C26) (25, 37) , bacterial glycolipids a-GlcA-DAG from Mycobacterium smegmatis (29), GSL-1 and GSL-19 from Sphingomonas spp. (28, 38) , and DGlcDAG from Staphylococcus aureus. Although iGb3 and GSL-1-loaded tetramers shared similar trends among the nine NKT cell lines, ligands such as a-L-FucCer, DGlcDAG, a-GlcA-DAG, GSL-19, and b-GalCer (C12) displayed CD1d tetramer staining patterns that were distinct from both iGb3 and a-GalCer (Fig. 5) . The influence of different CDR3b sequence usage was highlighted by comparing cell lines with the same VbJb pairings. For example, the Vb8.2-Jb2.7n2 line displayed the highest intensity staining for a-GalCer, whereas the Vb8.2-Jb2.7r2 line stained brightest for a-GlcA-DAG, DGlcDAG, and GSL-19, and Vb8.2-Jb2.7r1 conferred the brightest staining with a-L-FucCer (Fig. 5) . The fact that Ag-dependent differences were observed among such a limited selection of TCR sequences suggests that differential antigenic recognition among the NKT cell TCR repertoire may extend to a wider array of glycolipid Ags than previously appreciated. Consistent with an important role for TCRb diversity in glycolipid Ag recognition, CD1d tetramer staining on thymic NKT cells with these Ags revealed differential staining (Supplemental Fig. 3 ), suggesting that only those expressing particular TCR b-chains had sufficiently high avidity to be clearly labeled. Importantly, CD1d tetramers loaded with lower affinity NKT cell agonists, including iGb3, demonstrated limited staining on thymic NKT cells. This suggested that low-affinity interactions with CD1d-Ag, combined with the relatively low levels of TCR expressed by NKT cells ex vivo, may not provide sufficient avidity to achieve clear tetramer staining, even when CD1d is loaded with glycolipids that are demonstrably antigenic.
Distinct TCR Vb + NKT cell subsets display divergent antigenic preferences
To further investigate the correlation between b-chain diversity and differential Ag recognition, NKT cell-enriched mouse thymocytes were simultaneously costained with saturating concentrations of CD1d tetramers loaded with different glycolipid Ags, a technique we have previously demonstrated to segregate NKT cell subsets with divergent antigenic preferences (29) . The competitive nature of CD1d tetramer binding in this context resulted in some NKT cells being preferentially stained with one (Fig. 6A ) that were strikingly correlated with Vb usage (Fig. 6B) . Vb8 + NKT cells displayed a bias toward CD1d-OCH tetramer, compared with Vb7 + and Vb2 + NKT cells, which were biased toward CD1d-a-GlcCer tetramer (Fig. 6B) . The antigenic preferences of the minor Vb6 + NKT cell subsets (3, 39) were less obvious, but there did appear to be some variation; for example, Vb14 + NKT cells were preferentially bound by CD1d-a-GlcCer tetramer, whereas Vb9 + NKT cells displayed a bias toward CD1d-OCH tetramer staining (Fig. 6B) . The observation that for each TCR Vb, tetramer staining ranged from single-positive to double-positive and for some cells showed the opposite bias to the majority, supports the concept that although Vb usage influences Ag recognition by NKT cells, the additional diversity contributed by non-germline-and Jb-encoded residues are also important factors.
+ human NKT cells display divergent antigenic preferences
The degree of Vb-chain diversity among Va24 + Ja18 + human NKT cells is less extensive than their mouse counterparts, being largely restricted to Vb11, the human ortholog of mouse Vb8.2 (4, 40, 41) . However, similar to their mouse counterparts, human NKT cells also exhibit extensive Jb and non-germline-encoded diversity at the CDR3b junction. Given that Ag-dependent differences were observed among mouse NKT cell TCRs expressing the same Vb gene segment (Figs. 4, 5) , this raised the possibility that differential Ag recognition may also be present among human NKT cells. To investigate this, in vitro-expanded human NKT cells (sort purified from PBMCs, expanded in vitro with anti-CD3/anti-CD28/PHA/IL-2/IL-7) from two donors were costained with human CD1d tetramers loaded with several a-GalCer and a-GlcCer variants. Although cells from both donors were .98% Va24 + Vb11 + (Fig. 7A ), CD1d tetramer costaining segregated these cells into subsets, revealing differences in their antigenic preference (Fig. 7B) . These data suggest that, as in mice, TCR b-chain diversity has the potential to differentially influence CD1d-Ag recognition in humans. Furthermore, the observation that CD1d tetramer costaining profiles were distinct between donors suggests that the random nature of NKT cell TCR gene rearrangement could potentially generate Va24 + Ja18 + repertoires with divergent recognition characteristics in different individuals.
To explore potential correlations between TCR b-chain usage and preferential Ag recognition, the three most prominent subpopulations from each donor were single-cell sorted (Fig. 7C) for TCR sequence analysis. The majority of donor 1's NKT cells (population 1A) stained with similar intensity for a-GalCer-and a-GlcCer-loaded CD1d tetramers. From 22 derived sequences, five clones were identified expressing unique TCR b-chain sequences. Interestingly, two of these five clones had atypical CDR3a usages, where the Va24-encoded Ser residue was substituted with either a non-germline-encoded Thr or Phe at the Va24 and Ja18 junction. Population 1B exhibited a reduction in CD1d-a-GlcCer, but not CD1d-a-GalCer staining intensity compared with most cells from this donor. Only one sequence was derived from population 1B, which contained a Vb11-Jb1.1 gene pairing not observed among other NKT cells from this donor. In contrast, population 1C displayed similar staining intensity for CD1d-a-GlcCer as 1A; however, the intensity of a-GalCerloaded CD1d tetramer was reduced. NKT cells from 1C appeared to be clonal, with 22 of 22 TCR a-and b-chain sequences being identical. This TCR contained a unique CDR3a region, due to the deletion of the Va24-encoded Ser and the addition of a nongermline-encoded Asn residue at the Va24-Ja18 junction. This TCR was composed of a Vb11-Jb1.6 gene combination, as did one clone from 1A, with the only differences being deletions of germline and additions of non-germline-encoded residues in the FIGURE 5. The NKT cell TCR b-chain diversity confers differential Ag recognition. Graphs depict the ratio of glycolipid-loaded CD1d tetramer staining intensity (geometric mean fluorescence intensity) relative to a non-agonist control (Gb3-loaded CD1d tetramer) for each cell line and a TCR negative control (mean 6 SEM). Data are pooled from 3 to 12 independent experiments. CDR3a and CDR3b loops. Therefore, differences in CD1d tetramer costaining could not be specifically attributed to either TCR chain, but this does demonstrate the potential for random sequence variation to have Ag-dependent effects. The three subpopulations from donor 2 appeared more polyclonal, with 16 of the 48 cells sequenced carrying unique TCRs. The TCR a-chain sequences were almost entirely invariant, with only one clone containing a non-germline CDR3a residue, namely a Thr (Fig. 7C) , indicating that differences in CD1d tetramer costaining were likely a result of TCR b-chain diversity. No particular patterns stood out for TCR Jb-chain usage or CDR3b composition in either donor 1 or donor 2, other than that the TCR Jb distribution was largely distinct between different subpopulations (Fig. 7C) . This is in line with the findings from mouse NKT cells that Jb usage contributes to Ag-specific biases (Figs. 3-5 ). These data suggest that despite limited diversity among human Va24 + Vb11 + NKT cells, there remains scope for TCR b-chain composition to impact CD1d recognition in an Ag-dependent manner.
Discussion
TCR interactions with peptides presented by the MHC often involve the hypervariable CDR3 loops (reviewed in Ref. 7) . In contrast, the NKT TCR interacts with lipid Ags solely via the invariant TCR a-chain (6, 18, 42) , suggesting an innate-like characteristic of this receptor, a concept supported by mutant studies of the NKT TCR (14, 18, 43) . However the NKT TCR b-chain is diverse with our sequence analysis reiterating the hypervariable nature of the CDR3b repertoire (2-5), which encompasses considerable non-germline-encoded variation. Divergent CDR3b sequence usage has been reported to modulate affinity for CD1d in an Ag-independent manner (12) (13) (14) , consistent with previous structural reports that when the CDR3b loop is involved in these interactions, it solely contacts CD1d (reviewed in Ref. 6) . Surprisingly, our study has demonstrated that the composition of the CDR3b region modulates affinity for CD1d in an Ag-dependent manner, suggesting that there may be an immunological consequence of non-germline-encoded sequence variation within the NKT cell TCR b-chain beyond simply modulating the extent of autoreactivity (13) .
The results in this study support the correlation between Vb usage and the preferential recognition of CD1d-restricted ligands such as iGb3, a-GlcCer, and OCH (8-10), despite reports of the CDR1b and CDR2b loops not contacting Ag (reviewed in Ref. 6 ). Importantly, the observed Vb biases were dependent on the Jb/ CDR3b composition, indicating that both germline and nongermline components of the TCR are important, working in a complementary manner to modulate recognition of different glycolipid Ags. These findings provide a rationale for the differential responses to a-GalCer and iGb3 observed among a panel of Vb8.2 + NKT cell hybridomas expressing diverse Jb-CDR3b usages (15) . However, the presence of differential Ag recognition in the context of the same Vb-Jb pairings observed in the present study highlights the potential for non-germline-encoded residues within the CDR3b loop to have an Ag-dependent influence. This implies that differential antigenic recognition may not always manifest in clear Vb-or Jb-specific biases. A reason why previous studies did not detect preferential recognition of iGb3 by Vb7 + NKT cells may have been due to the use of a single Jb/CDR3b loop, derived from a non-NKT cell line that in combination with Vb7 did not favor preferential iGb3/CD1d binding (12) . In contrast, other studies that have demonstrated Ag-specific TCR Vb biases have used naturally occurring, polyclonal NKT TCR repertoires (8) (9) (10) 15) . Our data suggests that the extensive natural variation that exists within the NKT cell TCR b-chain repertoire needs to be considered when investigating the recognition of different CD1d-restricted ligands.
Previous studies have highlighted the importance of the CDR3b loop in modulating CD1d-glycolipid Ag binding, where different CDR3b loops engineered into NKT TCRs can either abrogate or enhance binding (12, 14, 44) . Moreover, prior investigations have suggested that trends within CDR3b sequence composition could be directly correlated with the recognition of self-ligands (16); however, our findings suggest a more collaborative role for the individual TCR b-chain components (Vb, Jb, and CDR3b) in determining specificity for individual glycolipid Ags. Although the observed Ag-specific influence of the TCR b-chain may seem somewhat counterintuitive considering the absence of direct CDRb interactions with glycolipid Ag (reviewed in Ref. 6 ), altered amino acid composition within the NKT cell TCR b-chain not only has the potential to affect TCR contacts with CD1d-Ag, it also has the potential to impact the structure of the abTCR heterodimer due to the molecular interplay between the a-and the b-chains (11, 18, 45) . Indeed, structural reports have previously demonstrated that CDR3a loop-mediated contacts with glycolipid Ag may be altered when NKT cell TCRs with different b-chains are used (11, 18) . Collectively, these data suggest that both germline and non-germline-encoded amino acid composition of the NKT cell TCR that do not directly contact glycolipid Ag may still have the potential to modulate Ag specificity.
The inability of most a-GalCer-reactive NKT cells to respond to the mammalian ligand iGb3 indicated that TCR b-chain diversity has the potential to limit activation to subsets of the NKT cell population. Analysis of TCR-transfected cell lines where individual NKT TCRs are expressed from low to very high levels suggested that this limited recognition was not solely the result of Ag specificity, rather, it may reflect a spectrum of avidity for CD1d-iGb3 throughout the population, mediated by both b-chain composition and TCR expression levels. Given that thymic NKT cells can vary considerably in their TCR expression levels (46) , this may also be a relevant factor in intrathymic NKT cell selection. In contrast, regardless of TCR expression levels, Gb3-loaded CD1d tetramers failed to stain these TCR transfected cells, regardless of their TCR levels. The potential for the NKT cell population to maintain spectrums of avidity for CD1d-Ag has been demonstrated previously using CD1d tetramers loaded with various bacterial ligands (28, 47, 48) , with similar observations being made in this investigation with regard to CD1d tetramers loaded with Ags other than a-GalCer. Therefore, the uniform reactivity of high-affinity synthetic Ags such as a-GalCer may obscure the variability of antigenic recognition that exists for lower affinity, physiologically relevant, CD1d-restricted ligands. These data provide rationale for the presence of contextdependent, immunodominant NKT cell subsets to exist as a function of TCR b-chain diversity.
